News about "Active Pharmaceutical Ingredients "

Piramal Pharma Solutions Commercialises Tablet-in-Capsule Technology at Indian Manufacturing Sites

Piramal Pharma Solutions Commercialises Tablet-in-Capsule Technology at Indian Manufacturing Sites

Piramal Pharma Solutions has successfully developed and commercialised a tablet-in-capsule drug delivery system in India, enabling flexible dosing, dual-release profiles and improved patient-centric oral therapies.

Active Pharmaceutical Ingredients | 03/02/2026 | By News Bureau 122

ChemWerth Appoints General Sales Manager to Expand API Presence in India

ChemWerth Appoints General Sales Manager to Expand API Presence in India

ChemWerth has appointed industry veteran Chandrakanth Reddy as General Sales Manager to drive growth in its generic API business in India, drawing on his 16+ years of experience across multiple global markets.

Active Pharmaceutical Ingredients | 13/01/2026 | By News Bureau

FDA Announces New ANDA Prioritisation Pilot to Support US Generic Drug Manufacturing and Testing

FDA Announces New ANDA Prioritisation Pilot to Support US Generic Drug Manufacturing and Testing

More than half of pharmaceuticals distributed in the US are manufactured overseas. Further, the US is reliant on overseas sources for Active Pharmaceutical Ingredients (APIs). As of 2025, only nine percent of API manufacturers are in the US, compared to 22 percent in China and 44 percent in India.

Active Pharmaceutical Ingredients | 06/10/2025 | By Dineshwori 123

Supriya Lifescience Secures WHO GMP Certification for Ambernath Facility

Supriya Lifescience Secures WHO GMP Certification for Ambernath Facility

The WHO certification for Supriya Lifescience paves way for commercial formulations’ production with INR 500 crore revenue potential.

Active Pharmaceutical Ingredients | 04/10/2025 | By Dineshwori 285

SwRI Scientists Develop Ion-Assisted Chromatography Process to Accelerate Drug Development

SwRI Scientists Develop Ion-Assisted Chromatography Process to Accelerate Drug Development

Scientists at Southwest Research Institute have accidently made a discovery of an ion-assisted chromatography process to accelerate drug development.

Active Pharmaceutical Ingredients | 28/08/2025 | By Dineshwori 136

NATCO Launches Tracleer Generic in US with Lupin

NATCO Launches Tracleer Generic in US with Lupin

NATCO Pharma has announced the launch of Bosentan tablets for oral suspension (TFOS), 32mg, a generic version of Tracleer by Actelion Pharmaceuticals US Inc., in partnership with Lupin.

Active Pharmaceutical Ingredients | 20/08/2025 | By Dineshwori 255

Veranova Names Thomas Rohrer as Vice President of Bioconjugation

Veranova Names Thomas Rohrer as Vice President of Bioconjugation

Veranova, a global leader in the development and manufacturing of specialty and complex active pharmaceutical ingredients (API) for the pharmaceutical and biotech sectors, has appointed Thomas Rohrer as Vice President of Bioconjugation.

Active Pharmaceutical Ingredients | 29/07/2025 | By Dineshwori 205

Medicines UK Hails India-UK Trade Deal, Calls for Clear Regulatory Pathway

Medicines UK Hails India-UK Trade Deal, Calls for Clear Regulatory Pathway

Medicines UK has called for the establishment of a clear regulatory framework to fully unlock the benefits of the newly signed Comprehensive Economic and Trade Agreement (CETA) between India and the UK.

Active Pharmaceutical Ingredients | 25/07/2025 | By Dineshwori 200

India Clears 48 Projects Under PLI Scheme to Boost Domestic Production of Key Drug Ingredients

India Clears 48 Projects Under PLI Scheme to Boost Domestic Production of Key Drug Ingredients

A total of 48 projects have been approved under the Production Linked Incentive (PLI) Scheme to boost domestic manufacturing of critical Key Starting Materials (KSMs), Drug Intermediates (DIs), and Active Pharmaceutical Ingredients (APIs) in India, according to the Ministry of Chemicals and Fertilizers.

Active Pharmaceutical Ingredients | 23/07/2025 | By Dineshwori 563

Dr. Reddy's Srikakulam Facility Gets Form 483 After USFDA Inspection

Dr. Reddy's Srikakulam Facility Gets Form 483 After USFDA Inspection

Dr. Reddy’s Laboratories has received a Form 483 with seven observations from the United States Food and Drug Administration (USFDA) following an inspection at its formulations manufacturing facility in Srikakulam, Andhra Pradesh.

Active Pharmaceutical Ingredients | 19/07/2025 | By Dineshwori 520


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members